Dogwood Therapeutics, Inc.
DWTX
$1.94
-$0.10-4.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.53M | -4.99M | -3.78M | -15.74M | -3.81M |
| Total Depreciation and Amortization | 16.70K | 16.80K | 16.60K | 17.30K | 17.30K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Other Non-Cash Items | 7.25M | 495.40K | 82.40K | 12.09M | 60.00K |
| Change in Net Operating Assets | 656.80K | -112.80K | 44.30K | 361.70K | -296.00K |
| Cash from Operations | -3.61M | -4.59M | -3.64M | -3.27M | -4.03M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 11.40M | 86.40K | 0.00 | -- |
| Repurchase of Common Stock | 0.00 | -106.30K | -- | -- | -120.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -53.80K | -- | -- |
| Cash from Financing | 0.00 | 11.29M | 32.60K | 0.00 | -120.10K |
| Foreign Exchange rate Adjustments | -6.70K | -1.00K | 2.70K | -3.30K | 10.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.62M | 6.70M | -3.60M | -3.28M | -4.14M |